(Q33366083)

English

Phase II study of G3139, a Bcl-2 antisense oligonucleotide, in combination with dexamethasone and thalidomide in relapsed multiple myeloma patients

scientific article

Statements

Phase II study of G3139, a Bcl-2 antisense oligonucleotide, in combination with dexamethasone and thalidomide in relapsed multiple myeloma patients (English)
Ashraf Z Badros
Olga Goloubeva
Aaron P Rapoport
Bashi Ratterree
Natalie Gahres
Barry Meisenberg
Naoko Takebe
Meyer Heyman
James Zwiebel
Howard Streicher
Christopher D Gocke
Dragana Tomic
Robert G Fenton
4089-4099

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit